PuroChem Limited focuses on separation technology. Dispersed Mobile-Phase Countercurrent Chromatography supports high resolution separation for different compounds at the industrial scale.
Current Status
Being a groundbreaking separation technology with clear advantages over existing technologies in scalability, cost and speed. DMCC was published in a top journal, Separation. A US patent has been granted for DMCC. The technology is under translation from the idea to a product.
Problem or Opportunity
Effective large scale purification of Wogonin from its analogs has been
especially challenging and essential for its therapeutic applications.
Solution (product or service)
This has motivated us to develop the new purification technology,
Dispersed Mobile-Phase Counter-current Chromatography (DMCC).
Business model
The DMCC equipment will be sold to phytochemistry and organic chemistry manufacturers and institutions. We will consider co-development DMCC protocols with our end-users in return for sales revenue and market penetration. We plan to have joint-design manufacture (pointer) and share the sales profits with the manufacturer partner. Also, we will consider licensing out our international market right for global revenue. Active pharmaceutical ingredients prepared by DMCC purification can be sold or licensed to pharmaceutical and nutraceutical companies. We also consider co-development with them.
Incubation/Acceleration programs accomplishment
Hong Kong Science and Technology Parks Corporation Incu-Bio Programme and Technology Start-up Support Scheme for Universities (TSSSU).
